No abstract available
Keywords:
assessment; biomarker; myasthenia gravis; phenotype; roadmap.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The draft of the roadmap as a part of this submission is partially supported by the National Natural Science Foundation of China (No. 82171397).